News

With an increasing shift toward preventive health and holistic wellness, natural supplements like berberine HCL have surged ...
A significant trial of a daily weight-loss pill has found that it helped people to shed the pounds and reduce their blood ...
Mounfit addresses one of the biggest reasons weight loss efforts fail-appetite dysregulation. It does this by incorporating ...
Lilly's weight-loss drug trial shows promising results, propelling stock up 14.36%. Goldman Sachs predicts potential $23.5B in sales by 2035.
Weight loss drugs come at a cost, and it is not the MRP you read on the packaging. There are practical complications that ...
Discover Mounjaro Tirzepatide's impact on obesity in India post its March launch. Get insights on effectiveness against diabetes, hypertension & more.
Science Natural Supplements Berberine Fat Burner Named Best Berberine Formula for Weight Loss, Blood Sugar & Gut Hea ...
Drugmaker Eli Lilly (NYSE: LLY) hasn't been exempt from the recent market pullback, but its stock shot higher following the ...
Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...
Pfizer abandoned the development of danuglipron and plans to focus its efforts on GIPR candidates and other earlier obesity programs.
Lowering cholesterol triggers other health problems. Mostly false. Prior to the introduction of statins four decades ago, ...
Breaking down the “Chain Reaction 2024” report; a new facility for Grip; and a GLP-1-friendly ice cream makes its debut.